Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 9,018 | 7,468 | 7,793 | 7,098 | 8,144 |
| Operating Income | -9,018 | -7,468 | -7,793 | -7,098 | -8,144 |
| Other Income | 1,264 | 1,239 | -2,037 | 817 | 653 |
| Pre-tax Income | -7,754 | -6,229 | -9,830 | -6,281 | -7,491 |
| Net Income Continuous | -7,754 | -6,229 | -9,830 | -6,281 | -7,491 |
| Net Income | $-7,754 | $-6,229 | $-9,830 | $-6,281 | $-7,491 |
| EPS Basic Total Ops | -0.90 | -0.75 | -1.20 | -0.75 | -0.90 |
| EPS Basic Continuous Ops | -0.93 | -0.74 | -1.16 | -0.74 | -0.89 |
| EPS Diluted Total Ops | -0.90 | -0.75 | -1.20 | -0.75 | -0.90 |
| EPS Diluted Continuous Ops | -0.93 | -0.74 | -1.16 | -0.74 | -0.89 |
| EBITDA(a) | $-9,004 | $-7,465 | $-7,790 | $-7,095 | $-8,142 |